ShenQi ShenKang Granule Alleviates Chronic Kidney Disease by Inhibiting the PI3K/AKT/mTOR Pathway and Restoring Autophagy Flux and Mitochondrial Integrity
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s513824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Chenhui Xia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Autophagy, TOR Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, People's Republic of China.
- Department of Renal Research, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, People's Republic of China.
- Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing, People's Republic of China.
- Department of Nephrology, Shenzhen Hospital Affiliated to Beijing University of Chinese Medicine, Shenzhen, Guangdong, People's Republic of China.
ORCID-Profile: Chenhui Xia, Jiale Zhang, Huijuan Zheng
Zitieren
APA
Xia, C., Zhang, J., Chen, H., Zhou, S., Jiang, W., Zheng, H., Lin, Z., Tan, Q., & Sun, W. (2025). ShenQi ShenKang Granule Alleviates Chronic Kidney Disease by Inhibiting the PI3K/AKT/mTOR Pathway and Restoring Autophagy Flux and Mitochondrial Integrity. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s513824
Vancouver
Xia C, Zhang J, Chen H, Zhou S, Jiang W, Zheng H, et al. ShenQi ShenKang Granule Alleviates Chronic Kidney Disease by Inhibiting the PI3K/AKT/mTOR Pathway and Restoring Autophagy Flux and Mitochondrial Integrity. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s513824
BibTeX
@article{Xia2025,
author = {Xia, Chenhui and Zhang, Jiale and Chen, Huixi and Zhou, Shaofeng and Jiang, Weimin and Zheng, Huijuan and Lin, Zaoqiang and Tan, Qinxiang and Sun, Weiwei},
title = {ShenQi ShenKang Granule Alleviates Chronic Kidney Disease by Inhibiting the PI3K/AKT/mTOR Pathway and Restoring Autophagy Flux and Mitochondrial Integrity},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s513824}
}
EUVIMED